Argo Blockchain
ARBK
Strategy
MSTR
BTCS Inc
BTCS
Canaan
CAN
Bit Origin
BTOG
US Stock MarketDetailed Quotes
URGN UroGen Pharma Ltd
- 10.770
- +0.230+2.18%
Close Feb 14 16:00 ET
- 11.480
- +0.710+6.59%
Post 20:01 ET
454.49MMarket Cap-3.57P/E (TTM)
10.830High10.485Low236.60KVolume10.600Open10.540Pre Close2.53MTurnover0.73%Turnover RatioLossP/E (Static)42.20MShares20.70052wk High17.80P/B348.28MFloat Cap9.78052wk Low--Dividend TTM32.34MShs Float69.568Historical High--Div YieldTTM3.27%Amplitude4.850Historical Low10.680Avg Price1Lot Size
UroGen Pharma Ltd News
UroGen Announces Subgroup Analysis Results For ENVISION Study Of UGN-102 In LG-IR-NMIBC; Comparable CR Rates And DOR Observed Across Tumor Burden And Focality Levels
UroGen Announces Results From Subgroup Analyses of the Pivotal ENVISION Trial Evaluating Impact of Baseline Tumor Burden and Focality on Response to UGN-102
Express News | D. Boral Capital Maintains Buy on UroGen Pharma, Maintains $25 Price Target
Insider Sale: Chief Medical Officer of $URGN Sells 1,896 Shares
UroGen Pharma to Present at Upcoming Investor Conferences
Express News | UroGen Highlights Results From Study On Durability Of Response From Post-Commercialization Of JELMYTO Titled 'Durability of Response of UGN-101: Longitudinal Follow-Up of Multicenter Study'
New Real-World Durability of Response Data for JELMYTO Reports 68% Recurrence-Free Survival Rate (RFS) at Three Years Across a Broad Patient Population With Low-Grade Upper Tract Urothelial Cancer (LG-UTUC)
Express News | UroGen Pharma Shares Are Trading Higher After the Company Reported Its ENVISION Trial Results in the February Issue of The Journal of Urology
Why KB Home Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
PriceSmart Posts Weak Earnings, Joins Roku And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Breakeven On The Horizon For UroGen Pharma Ltd. (NASDAQ:URGN)
UroGen Pharma Is Maintained at Buy by D. Boral Capital
UroGen Pharma Price Target Maintained With a $25.00/Share by D. Boral Capital
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
UroGen Pharma Announces UGN-102 Long-Term Results In The Phase 3 ENVISION Trial, Potentially Paving The Way For First FDA-Approved Treatment For LG-IR-NMIBC; UGN-102 Demonstrated 82.3% Duration Of Response At 12 Months In Patients Who Achieved...
UGN-102 Showed Promising Long-Term Results in the Phase 3 ENVISION Trial, Potentially Paving the Way for First FDA-Approved Treatment for LG-IR-NMIBC
UroGen Announces New Data Presentations at the Society of Urologic Oncology 2024 Annual Meeting Highlighting Urothelial Cancer Portfolio Aimed at Addressing Unmet Needs
UroGen Pharma Presents New Data From A Long-Term Follow-Up Study Published In The Journal Of Urology Online To The OLYMPUS Trial Show Median Duration Of Response Of 4-Years In Patients Who Achieved A Complete Response With JELMYTO
New Data From a Long-Term Follow-up Study to the OLYMPUS Trial Show Median Duration of Response of Four Years in Patients Who Achieved a Complete Response With JELMYTO
Further Weakness as UroGen Pharma (NASDAQ:URGN) Drops 13% This Week, Taking Five-year Losses to 64%
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.